nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—UGT1A3—Estrogen metabolism—COMT—conduct disorder	0.0905	0.0905	CbGpPWpGaD
Etodolac—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.077	0.077	CbGpPWpGaD
Etodolac—UGT1A9—Estrogen metabolism—COMT—conduct disorder	0.0625	0.0625	CbGpPWpGaD
Etodolac—UGT1A10—Metapathway biotransformation—COMT—conduct disorder	0.0369	0.0369	CbGpPWpGaD
Etodolac—RXRA—Orphan transporters—GABRA2—conduct disorder	0.0367	0.0367	CbGpPWpGaD
Etodolac—UGT1A3—Phase II conjugation—COMT—conduct disorder	0.0254	0.0254	CbGpPWpGaD
Etodolac—RXRA—REV-ERBA represses gene expression—EP300—conduct disorder	0.0245	0.0245	CbGpPWpGaD
Etodolac—RXRA—RORA activates circadian gene expression—EP300—conduct disorder	0.0237	0.0237	CbGpPWpGaD
Etodolac—UGT1A3—NRF2 pathway—SLC6A4—conduct disorder	0.0224	0.0224	CbGpPWpGaD
Etodolac—RXRA—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0221	0.0221	CbGpPWpGaD
Etodolac—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.0216	0.0216	CbGpPWpGaD
Etodolac—RXRA—Retinoic acid receptors-mediated signaling—EP300—conduct disorder	0.0205	0.0205	CbGpPWpGaD
Etodolac—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.019	0.019	CbGpPWpGaD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0183	0.0183	CbGpPWpGaD
Etodolac—RXRA—NRF2 pathway—SLC6A4—conduct disorder	0.0177	0.0177	CbGpPWpGaD
Etodolac—UGT1A9—Phase II conjugation—COMT—conduct disorder	0.0176	0.0176	CbGpPWpGaD
Etodolac—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—conduct disorder	0.0173	0.0173	CbGpPWpGaD
Etodolac—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0157	0.0157	CbGpPWpGaD
Etodolac—UGT1A9—NRF2 pathway—SLC6A4—conduct disorder	0.0155	0.0155	CbGpPWpGaD
Etodolac—UGT1A3—Biological oxidations—COMT—conduct disorder	0.0149	0.0149	CbGpPWpGaD
Etodolac—UGT1A3—Biological oxidations—MAOA—conduct disorder	0.0148	0.0148	CbGpPWpGaD
Etodolac—UGT1A3—Metapathway biotransformation—COMT—conduct disorder	0.0147	0.0147	CbGpPWpGaD
Etodolac—RXRA—Regulation of Androgen receptor activity—EP300—conduct disorder	0.013	0.013	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0127	0.0127	CbGpPWpGaD
Etodolac—UGT2B7—Biological oxidations—COMT—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Etodolac—RXRA—Circadian Clock—EP300—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Etodolac—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Etodolac—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.0125	0.0125	CbGpPWpGaD
Etodolac—RXRA—Biological oxidations—COMT—conduct disorder	0.0118	0.0118	CbGpPWpGaD
Etodolac—RXRA—Biological oxidations—MAOA—conduct disorder	0.0117	0.0117	CbGpPWpGaD
Etodolac—UGT1A9—Biological oxidations—COMT—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Etodolac—UGT1A9—Biological oxidations—MAOA—conduct disorder	0.0102	0.0102	CbGpPWpGaD
Etodolac—UGT1A9—Metapathway biotransformation—COMT—conduct disorder	0.0101	0.0101	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.01	0.01	CbGpPWpGaD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—conduct disorder	0.00962	0.00962	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00895	0.00895	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00874	0.00874	CbGpPWpGaD
Etodolac—PTGS1—Biological oxidations—COMT—conduct disorder	0.00838	0.00838	CbGpPWpGaD
Etodolac—PTGS1—Biological oxidations—MAOA—conduct disorder	0.00832	0.00832	CbGpPWpGaD
Etodolac—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00823	0.00823	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00819	0.00819	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00785	0.00785	CbGpPWpGaD
Etodolac—RXRA—PPARA activates gene expression—EP300—conduct disorder	0.00723	0.00723	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00713	0.00713	CbGpPWpGaD
Etodolac—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00708	0.00708	CbGpPWpGaD
Etodolac—UGT1A9—PPARA activates gene expression—EP300—conduct disorder	0.0063	0.0063	CbGpPWpGaD
Etodolac—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00617	0.00617	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00566	0.00566	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CGA—conduct disorder	0.00564	0.00564	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—POLR3A—conduct disorder	0.00547	0.00547	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—EP300—conduct disorder	0.00506	0.00506	CbGpPWpGaD
Etodolac—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00488	0.00488	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CGA—conduct disorder	0.00479	0.00479	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00465	0.00465	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00458	0.00458	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CGA—conduct disorder	0.00447	0.00447	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—COMT—conduct disorder	0.0044	0.0044	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00437	0.00437	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00434	0.00434	CbGpPWpGaD
Etodolac—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00425	0.00425	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00408	0.00408	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CGA—conduct disorder	0.00389	0.00389	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00375	0.00375	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CGA—conduct disorder	0.00317	0.00317	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00262	0.00262	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—COMT—conduct disorder	0.00254	0.00254	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—MAOA—conduct disorder	0.00253	0.00253	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CGA—conduct disorder	0.00252	0.00252	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—EP300—conduct disorder	0.00218	0.00218	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—COMT—conduct disorder	0.00216	0.00216	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—MAOA—conduct disorder	0.00215	0.00215	CbGpPWpGaD
Etodolac—ALB—Metabolism—CGA—conduct disorder	0.00204	0.00204	CbGpPWpGaD
Etodolac—RXRA—Metabolism—COMT—conduct disorder	0.00202	0.00202	CbGpPWpGaD
Etodolac—RXRA—Metabolism—MAOA—conduct disorder	0.002	0.002	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—COMT—conduct disorder	0.00176	0.00176	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—MAOA—conduct disorder	0.00175	0.00175	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00169	0.00169	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CGA—conduct disorder	0.00167	0.00167	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—COMT—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—MAOA—conduct disorder	0.00142	0.00142	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—COMT—conduct disorder	0.00114	0.00114	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—MAOA—conduct disorder	0.00113	0.00113	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0011	0.0011	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—EP300—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Etodolac—ALB—Hemostasis—EP300—conduct disorder	0.000973	0.000973	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—EP300—conduct disorder	0.000928	0.000928	CbGpPWpGaD
Etodolac—ALB—Metabolism—COMT—conduct disorder	0.00092	0.00092	CbGpPWpGaD
Etodolac—ALB—Metabolism—MAOA—conduct disorder	0.000914	0.000914	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000886	0.000886	CbGpPWpGaD
Etodolac—RXRA—Metabolism—EP300—conduct disorder	0.000865	0.000865	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—EP300—conduct disorder	0.000754	0.000754	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—COMT—conduct disorder	0.000753	0.000753	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MAOA—conduct disorder	0.000748	0.000748	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000725	0.000725	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—EP300—conduct disorder	0.000614	0.000614	CbGpPWpGaD
Etodolac—PTGS2—Disease—EP300—conduct disorder	0.000582	0.000582	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—EP300—conduct disorder	0.000488	0.000488	CbGpPWpGaD
Etodolac—ALB—Metabolism—EP300—conduct disorder	0.000395	0.000395	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—EP300—conduct disorder	0.000323	0.000323	CbGpPWpGaD
